iAmericas (Industries of the Americas) Company Profile

Background

Company Name: Industries of the Americas, Inc. (IA)

Mission: To revitalize American manufacturing by producing high-quality medical and safety products domestically, thereby reducing reliance on overseas imports and supporting the U.S. economy.

Vision: To become a leading provider of medical and safety products in North America, recognized for innovation, quality, and commitment to domestic manufacturing.

Primary Area of Focus: Manufacturing of medical supplies, including latex gloves, thermal packs, surgical marking products, and disposable scalpels.

Industry Significance: IA plays a crucial role in reshoring manufacturing to the United States, addressing the growing demand for domestically produced medical supplies and contributing to the stability and security of the healthcare supply chain.

Key Strategic Focus

Core Objectives:

• Reshoring Manufacturing: Shift production from overseas to the U.S. to enhance supply chain resilience and reduce dependency on foreign imports.

• Product Diversification: Expand the range of medical and safety products manufactured domestically to meet various healthcare needs.

• Quality Assurance: Implement stringent quality control measures to ensure products meet or exceed industry standards.

Specific Areas of Specialization:

• Latex Gloves: Production of industrial-grade powdered latex gloves and plans to manufacture latex exam and surgical gloves.

• Thermal Packs: Manufacture of disposable cold packs and thermal packs for medical applications.

• Surgical Products: Development of surgical marking products and disposable scalpels.

Key Technologies Utilized:

• Latex Dipping Technology: Advanced machinery for producing latex gloves and other dipped latex products.

• Thermal Packaging Technology: Equipment for creating thermal packs used in medical settings.

Primary Markets Targeted:

• North America: Focus on the U.S. market with plans to expand into other North American regions.

• Healthcare Providers: Supplying products to hospitals, clinics, and other medical facilities.

• Distributors and Wholesalers: Engaging with distribution channels to reach a broader customer base.

Financials and Funding

Funding History:

• Capital Raised: Approximately $50 million, comprising real assets, intellectual property, and investments in engineering and operational capabilities.

• Recent Funding Rounds: The company has restructured its balance sheet by converting nearly all of its debt into a new class of preferred equity, aiming to eliminate derivative liabilities and increase paid-in capital.

• Notable Investors: Specific investor details are not publicly disclosed.

Intended Utilization of Capital:

• Manufacturing Expansion: Enhance production facilities to increase output and product variety.

• Research and Development: Invest in developing new products and improving existing ones.

• Market Expansion: Strengthen distribution networks and explore new market opportunities.

Pipeline Development

Key Pipeline Candidates:

• Latex Exam Gloves: Development underway to produce latex exam gloves domestically.

• Surgical Gloves: Plans to manufacture surgical gloves to meet healthcare demands.

• Surgical Marking Products: Introduction of new surgical marking products to enhance medical procedures.

• Disposable Scalpels: Development of disposable scalpels for surgical applications.

Stages of Development:

• Latex Gloves: Industrial-grade powdered latex gloves are currently in production.

• Thermal Packs: Disposable cold packs are being produced, with plans to expand the range.

• Surgical Products: In the development phase, with prototypes being tested.

Target Conditions:

• Latex Gloves: General medical use, including examinations and surgical procedures.

• Thermal Packs: Medical applications requiring temperature control, such as injury treatment and surgical procedures.

• Surgical Products: Medical procedures requiring precise surgical marking and cutting instruments.

Anticipated Milestones:

• Latex Gloves: Full-scale production expected to commence in the coming months.

• Thermal Packs: Expanded product line anticipated within the next year.

• Surgical Products: Market introduction planned within the next 18 months.

Technological Platform and Innovation

Proprietary Technologies:

• Latex Dipping Technology: Advanced machinery for producing high-quality latex products.

• Thermal Packaging Technology: Innovative methods for creating effective thermal packs.

Significant Scientific Methods:

• Quality Control Protocols: Rigorous testing and quality assurance processes to ensure product safety and efficacy.

• Product Development Research: Ongoing research to develop new products and improve existing ones.

Leadership Team

Key Executives:

• David Silver: Chief Executive Officer (CEO).

• Professional Background: Extensive experience in manufacturing and operations management.

• Key Contributions: Led the restructuring of the company's balance sheet and spearheaded the expansion of manufacturing capabilities.

• Abraham Summers: Chairman of the Board, President.

• Professional Background: Background in corporate governance and strategic planning.

• Key Contributions: Provides strategic direction and oversight for the company's operations.

• Denise Berry: Chief Financial Officer, Director Nominee.

• Professional Background: Experience in financial management and corporate finance.

• Key Contributions: Oversees financial operations and plays a key role in the company's financial planning and capital management.